Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
HBL 100 |
Human transformed epithelial cell line | Human | breast | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene PRO | publication | A. M. Scherbakov et al., Exp. Cell Res., 2013, 319: 3150 – 3159, doi.org/10.1016/j.yexcr.2013.08.019 | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | stem cell | adherent | siRNA | Metafectene PRO | publication | E. J. Lee, Mol. Therapy, 2018, doi: 10.1016/j.ymthe.2017.12.015 | ||||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | stem cell | adherent | plasmid | Metafectene | publication | D. Malik et al., PLoSONE, 13(9):e0203614, doi.org/10.1371/journal.pone.0203614 | Link | |||
hBMSC |
Human bone marrow-derived mesenchymal stem cells | Human | bone | primary cell | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. J. Lee et al., Mol. Therapy, 2017, 26(3): 845-859, doi.org/10.1016/j.ymthe.2017.12.015 | Link | ||
hBVP |
Human brain vascular pericytes | Human | brain | unknown | adherent | mRNA | K2 Transfection System | application note | ![]() |
||||
hBVP |
Human brain vascular pericytes | Human | brain | unknown | adherent | plasmid | K2 Transfection System | application note | ![]() |
||||
HC11 |
Mouse immortalized prolactin-responsive mammary epithelial cells | ATCC CRL-3062 | Mouse | breast | cell line | adherent | plasmid | Metafectene | publication | J. Seong., PhD Thesis, Seoul National University | Link | ||
HC11 |
Mouse immortalized prolactin-responsive mammary epithelial cells | ATCC CRL-3062 | Mouse | breast | cell line | adherent | plasmid | Metafectene | publication | J. Seong et al., Development, 2018, 145: dev165258, doi:10.1242/dev.165258 | Link | ||
HCC-44 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link | |||
HCC-515 |
Human lung adenocarcinoma cell line | Human | respiratory system | cell line | adherent | plasmid | Metafectene PRO | publication | J. Berrout et al., Nature Communications, 2017,8: 947, DOI: 10.1038/s41467-017-00983-w | Link | |||
hCMEC/D3 |
Human brain-derived microvascular endothelial cells | Human | brain | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Krishnan et al.,Oncotarget, 2015, 6(26): 22480-22495 | Link | ||
hConEC |
Human primary conjunctival epithel cells | Human | sensory organs | primary cell | adherent | miRNA | Metafectene SI | publication | Q. Pilson et al., Scientific Reports, 2020, 10: 7484, doi.org/10.1038/s41598-020-64422-5 | Link | |||
HCT-116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob-Schwarzl et al., Oncotarget, 2017, 8(60): 101224-101243 | Link | |
HCT-116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Schulz et al., Scientific Reports, 2018, 8: 2395, DOI:10.1038/s41598-018-19201-8 | Link | |
HCT-8 |
Human ileocecal colorectal adenocarcinoma cell line | ATCC CCL-244 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | publication | S. Möltgen et al., Cells, 2020, 9, 1322, doi:10.3390/cells9061322 | Link | |
HCT-8 |
Human ileocecal colorectal adenocarcinoma cell line | ATCC CCL-244 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | application note | ![]() |
||
HCT-8ox |
Human oxaliplatin-resistant ileocecal colorectal adenocarcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | K4 Transfection System | application note | ![]() |
|||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A.-K. Schmidt et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.10.11.463929 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | N. P. Bendeck, Dissertation, 2016, Universidad Complutense de Madrid | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | J. Galán‐Martínez et al., Mol. Oncology, 2021, doi:10.1002/1878-0261.13085 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | protein | Metafectene | publication | B. D’Orsi et al., Injury. Front. Cell Dev., 9: 750100, doi: 10.3389/fcell.2021.750100 | Link | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | S. T. Al Rashid et al., Cancer Res., Dec 2005; 65: 10810 - 10821 | Link | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | Metafectene | publication | D. Kobelt et al., Mol. Biotechnol., Mol Biotechnol, 2013, 53:80-89 |